Discover 471 paid clinical trials in Little Rock, Arkansas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 471
Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma
for
Neuroblastoma
Location: Little Rock AR, St Louis MO, Birmingham AL,
Sponsor: Giselle Sholler
Sex: All
Age: 1 - 21
Code: NCT05489887
Phase2, Recruiting
Safety and Efficacy Extension Study of GreenGene™ F in Previously Treated Patients Diagnosed With Severe Hemophilia A
for
Hemophilia A
Location: Little Rock AR, New Hyde Park NY
Sponsor: Green Cross Corporation
Sex: All
Age: 0+
Code: NCT02027779
Phase3, Recruiting
Targeted Reversal of Inflammation in Pediatric Sepsis-induced MODS
for
Pediatric Sepsis-induced Multiple Organ Dysfunction Syndrome (MODS),
Location: Little Rock AR, Dallas TX, Birmingham AL,
Sponsor: Nationwide Children's Hospital
Sex: All
Age: 0 - 17
Code: NCT05267821
Phase2, Phase3, Recruiting
A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
The Effect of Bethanechol on Tracheobronchomalacia
for
Tracheobronchomalacia
Location: Little Rock AR
Sponsor: Arkansas Children's Hospital Research Institute
Sex: All
Age: 0+
Code: NCT05299008
Recruiting
Percutaneous Intervention Versus Observational Trial of Arterial Ductus in Low Weight Infants
for
Ductus Arteriosus, Patent
Location: Little Rock AR, Memphis TN, Dallas TX, Saint Louis MO,
Sponsor: Nationwide Children's Hospital
Sex: All
Age: 0
Code: NCT05547165
Recruiting
National Collaborative to Improve Care of Children With Complex Congenital Heart Disease
for
Hypoplastic Left Heart Syndrome (HLHS)
Location: Little Rock AR, Memphis TN, Jackson MS, St Louis MO,
Sponsor: Children's Hospital Medical Center, Cincinnati
Sex: All
Age: 0 - 1
Code: NCT02852031
Recruiting
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
for
Sickle Cell Disease
Location: Little Rock AR, Memphis TN, St Louis MO,
Sponsor: Novo Nordisk A/S
Sex: All
Age: 12+
Code: NCT06612268
Phase3, Recruiting
Safety, Efficacy and Pharmacokinetics of GreenGene™ F to Previously Treated Patients With Severe Hemophilia A
for
Hemophilia A
Location: Little Rock AR, Kansas City MO, Chicago IL,
Sponsor: Green Cross Corporation
Sex: All
Age: 12+
Code: NCT01619046
Phase3, Recruiting
A Study of Patients With Fabry Disease (US Specific)
for
Fabry Disease
Location: Little Rock AR, Dallas TX, St Louis MO, Birmingham AL,
Sponsor: Amicus Therapeutics
Sex: All
Age: 18+
Code: NCT06906367
Recruiting
The Diaphragmatic Initiated Ventilatory Assist (DIVA) Trial
for
Extubation Failure, Bronchopulmonary Dysplasia, Death
Location: Little Rock AR, St Louis MO, Kansas City MO,
Sponsor: University of Pennsylvania
Sex: All
Age: 0
Code: NCT05446272
Recruiting
Hyperhydration in Children With Shiga Toxin-Producing E. Coli Infection
for
Shiga Toxin-Producing Escherichia Coli (E. Coli) Infection,
Location: Little Rock AR, St Louis MO, Oklahoma City OK,
Sponsor: University of Calgary
Sex: All
Age: 0 - 21
Code: NCT05219110
Recruiting
A Real Life Evaluation of the Performance of a Large Volume Nebulizer
for
Asthma
Location: Little Rock AR
Sponsor: Arkansas Children's Hospital Research Institute
Sex: All
Age: 0 - 21
Code: NCT00632112
Recruiting
Digoxin Medulloblastoma Study
for
Medulloblastoma, Medulloblastoma, Non-WNT/Non-SHH
Location: Little Rock AR, St Louis MO, Dallas TX, Nashville TN,
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Sex: All
Age: 1 - 30
Code: NCT06701812
Phase2, Recruiting
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue